BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9024747)

  • 21. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation.
    Julius BK; Attenhofer Jost CH; Sütsch G; Brunner HP; Kuenzli A; Vogt PR; Turina M; Hess OM; Kiowski W
    Transplantation; 2000 Mar; 69(5):847-53. PubMed ID: 10755538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: influence of pre-existent donor atherosclerosis.
    Wong CK; Yeung AC
    J Heart Lung Transplant; 2001 Aug; 20(8):858-64. PubMed ID: 11502408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study.
    Huibers MM; Vink A; Kaldeway J; Huisman A; Timmermans K; Leenders M; Schipper ME; Lahpor JR; Kirkels HJ; Klöpping C; de Jonge N; de Weger RA
    Atherosclerosis; 2014 Oct; 236(2):353-9. PubMed ID: 25128973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.
    Tuzcu EM; Kapadia SR; Sachar R; Ziada KM; Crowe TD; Feng J; Magyar WA; Hobbs RE; Starling RC; Young JB; McCarthy P; Nissen SE
    J Am Coll Cardiol; 2005 May; 45(9):1538-42. PubMed ID: 15862431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW; Collins TC; Ramee SR
    J Heart Lung Transplant; 1995; 14(4):632-9. PubMed ID: 7578168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Young JB; Crowe T; Ratliff NB; Cook DJ; Hobbs R; Bott-Silverman C; Rincon G; Smedira N; Tuzcu EM
    Transplant Proc; 2004 Dec; 36(10):3129-31. PubMed ID: 15686711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487
    [No Abstract]   [Full Text] [Related]  

  • 29. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
    J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound.
    Yamani MH; Tuzcu EM; Starling RC; Young JB; Cook DJ; Haji SA; Abdo A; Crowe T; Hobbs R; Rincon G; Bott-Silverman C; McCarthy PM; Ratliff NB
    J Heart Lung Transplant; 2002 Aug; 21(8):850-9. PubMed ID: 12163084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries.
    Clausell N; Butany J; Molossi S; Lonn E; Gladstone P; Rabinovitch M; Daly PA
    J Am Coll Cardiol; 1995 Jul; 26(1):110-9. PubMed ID: 7541058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis on coronary angiography is a marker for accelerated cardiac allograft vasculopathy as assessed by intravascular ultrasound.
    Cheng R; Kransdorf EP; Wei J; Patel JK; Kobashigawa JA; Azarbal B
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28786501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac allograft vasculopathy can be distinguished from donor-transmitted coronary atherosclerosis by optical coherence tomography imaging in a heart transplantation recipient: double layered intimal thickness.
    Imamura T; Kinugawa K; Murasawa T; Kagami Y; Endo M; Muraoka H; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Komuro I; Ono M
    Int Heart J; 2014; 55(2):178-80. PubMed ID: 24632967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intimal thickening at coronary bifurcations in pediatric heart transplant recipients.
    Duncombe SL; Hosking MCK; Coté AT; Voss C; Harris KC
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29266632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
    N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Uber PA; Ventura HO; Scott RL; Park MH
    J Am Coll Cardiol; 2004 Mar; 43(5):806-10. PubMed ID: 14998621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors.
    Pethig K; Klauss V; Heublein B; Mudra H; Westphal A; Weber C; Theisen K; Haverich A
    Heart; 2000 Nov; 84(5):494-8. PubMed ID: 11040007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.
    Escobar A; Ventura HO; Stapleton DD; Mehra MR; Ramee SR; Collins TJ; Jain SP; Smart FW; White CJ
    Am J Cardiol; 1994 Nov; 74(10):1042-6. PubMed ID: 7977044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in coronary arterial dimensions early after cardiac transplantation.
    Fearon WF; Potena L; Hirohata A; Sakurai R; Yamasaki M; Luikart H; Lee J; Vana ML; Cooke JP; Mocarski ES; Yeung AC; Valantine HA
    Transplantation; 2007 Mar; 83(6):700-5. PubMed ID: 17414701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation.
    Topilsky Y; Raichlin E; Hasin T; Boilson BA; Schirger JA; Pereira NL; Edwards BS; Clavell AL; Rodeheffer RJ; Frantz RP; Gandhi MJ; Maltais S; Park SJ; Daly RC; Lerman A; Kushwaha SS
    Transplantation; 2013 Mar; 95(6):859-65. PubMed ID: 23364484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.